2022 annual financial data
Myriad Genetics 2022 Operating margin
Direct answer
Operating margin was -18.23%.
Operating income was -123,700,000 USD and net income was -112,000,000 USD.
Operating cash flow was -106,300,000 USD.
Get free Myriad Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 678,400,000 USD
- Operating income
- -123,700,000 USD
- Net income
- -112,000,000 USD
- Operating cash flow
- -106,300,000 USD